The U.S. may be further into Delta surge than it appears
Just how far along into the latest Delta variant-fueled coronavirus surge is the United States? No one knows for sure, but former Food and Drug Administration Commissioner Scott Gottlieb is hopeful the country can "turn a corner" in just two or three weeks, he told CBS News' John Dickerson on Sunday's edition of Face the Nation.
There's a couple of reasons behind the relatively optimistic outlook. For starters, Gottlieb, who has criticized the Centers for Disease Control and Prevention's wide-ranging forecasts for the current wave, believes it's likely there are a lot of mild or subclinical infections in the U.S., which means the number of cases picked up by testing is probably an underestimate of the virus' actual spread. He's also looking across the pond to the United Kingdom, where cases appear to be trending downward again after rising for several weeks. The U.K., Gottlieb noted, has been a few weeks ahead of the U.S. so far and could serve as a sneak preview of the national trajectory.
FiveThirtyEight's Nate Silver also thinks it's worth paying attention to the U.K., as well as India, where the Delta variant originated. Their most recent waves were big ones, but they did appear to turn around quite quickly.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Of course, the U.K. needs to show that it can sustain its recent drop, and either way, the U.S. will likely have a less cohesive path out of the latest wave given the disparate vaccination rates across the country.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
‘The Big Crunch’: why science is divided over the future of the universeThe Explainer New study upends the prevailing theory about dark matter and says it is weakening
-
Quiz of The Week: 1 – 7 NovemberQuiz Have you been paying attention to The Week’s news?
-
How to invest in the artificial intelligence boomThe Explainer Artificial intelligence is the biggest trend in technology, but there are fears that companies are overvalued
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
